β3Gn-T1, also known as β-1,3-N-acetylglucosaminyltransferase 1, is an enzyme involved in the biosynthesis of complex N-glycans, which are carbohydrate structures attached to proteins and play essential roles in various cellular processes such as cell adhesion, signaling, and immune response. As a member of the glycosyltransferase family, β3Gn-T1 catalyzes the transfer of N-acetylglucosamine (GlcNAc) residues from UDP-GlcNAc to specific glycoprotein substrates, thereby initiating the formation of complex N-glycan chains. The function of β3Gn-T1 is crucial for the proper glycosylation of proteins, as it determines the structure and composition of N-glycans, which in turn influences protein folding, stability, trafficking, and function. Additionally, β3Gn-T1-mediated glycosylation events have been implicated in cell-cell interactions, immune recognition, and the regulation of cellular signaling pathways.
The activation of β3Gn-T1 involves complex regulatory mechanisms that govern its expression, localization, and enzymatic activity. Transcriptional regulation plays a key role in activating β3Gn-T1, with various signaling pathways and transcription factors influencing its gene expression in response to cellular stimuli or developmental cues. Additionally, post-translational modifications such as phosphorylation or glycosylation may regulate the activity or stability of β3Gn-T1, thereby modulating its catalytic efficiency and substrate specificity. Furthermore, the availability of substrates and co-factors, such as UDP-GlcNAc and divalent metal ions, may influence the enzymatic activity of β3Gn-T1 and contribute to its activation. Elucidating the precise mechanisms underlying β3Gn-T1 activation will provide valuable insights into its physiological roles in glycosylation processes and its implications in health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin promotes the production of cAMP, which activates PKA. PKA, in turn, increases the phosphorylation of proteins involved in the same signaling pathways as β3Gn-T1, enhancing its activity. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP directly activates Protein Kinase A (PKA). PKA phosphorylation leads to the activation of proteins functionally linked with β3Gn-T1, thus enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, which degrade cAMP. By elevating cAMP levels, IBMX can indirectly enhance β3Gn-T1 by activating PKA, which phosphorylates proteins in the β3Gn-T1 functional pathway. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP, a cell-permeable cAMP analog, activates PKA which then phosphorylates proteins within the same functional pathway as β3Gn-T1, enhancing its activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 inhibits PKA, thereby modulating the phosphorylation status of proteins within the β3Gn-T1 functional pathway, indirectly enhancing β3Gn-T1 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases like PKA. By modulating the phosphorylation status of proteins in the β3Gn-T1 pathway, it indirectly augments β3Gn-T1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which can decrease Akt pathway activity. This decrease indirectly enhances β3Gn-T1 activity by reducing competitive signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, leading to a decrease in Akt activity. This can indirectly enhance β3Gn-T1 activity by reducing competition in signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can indirectly enhance β3Gn-T1 activity by reducing Akt activity and subsequent competitive signaling. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
BEZ235 inhibits both PI3K and mTOR, reducing Akt activity and enhancing β3Gn-T1 activity indirectly through decreased competition in signaling. | ||||||